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Abstract—Techniques for monitoring ambulatory patients 
have advanced greatly over the past 10 years. The advent of 
pocket computing, in the form of cellular phone technology, 
being one of the prime drivers. Until recently there was a 
great functional deficit in the performance of the average 
portable microprocessor and that which was used in the 
personal desktop computer. Today, smart phones have 1GHz 
processors and use multicore configurations. Memory has 
accelerated at a similar rate, with 128Gb flash memory being 
common place.  
The following paper discusses the viability of an arm worn 
‘smart’ device for monitoring cardiac dysrhythmia and or 
electrocardiographic dysmorphia. As there is particular 
interest from the medical community in the field of 
monitoring of paroxysmal atrial fibrillation; the proposed 
technology will be a front line diagnostic tool for primary care 
clinicians, allowing them to offer a non-surgical, long term 
monitor. Alternatively, the commercial possibilities of 
marketing a clinical quality, ‘smart band’ cardiac monitor 
into the consumer space are immense.   
This paper deals with emerging digital signal processing 
techniques as well as discussing the underlying hardware 
requirements that may allow the full realisation of this new 
technology. 
Keywords—ECG; dysrhythmia; DSP; long term monitor; 
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I.  INTRODUCTION  
Heart disease remains a common killer of both the old 
and the young [1], making a strong case for the 
development of a long term monitoring technology that is 
non-invasive and comfortable to wear. Also, with recent 
research alluding toward an increased detectability of latent 
cardiac abnormalities as the subject stands from a seated 
position [2], the desirability and marketability of an arm 
worn smart sensor is increasingly realised [3].  
The effect of drugs on the heart rhythm is widely noted 
in the literature. An example being those which are linked 
with QT elongation or torsade de pointes.  Domperidone, 
for instance, has been associated with a small increased 
risk of serious ventricular dysrhythmia or sudden cardiac 
death [4,5]. A QT prolongation warning strategy for 
patients continuously monitored during their course of 
treatment would significantly de-risk the administration 
period.  
Atrial fibrillation (AF) affects almost 800,000 people in 
the UK, predominantly over 75 year olds with an affect rate 
of 10%. AF is uncommon in younger people; however, it 
may be coincidental with other heart defects such as heart 
valve problems [6]. Gauging the time a patient spends in 
paroxysmal atrial fibrillation will determine the treatment 
plan. Current non-invasive analysis and recording 
equipment, such as the Omron HCG801 [7], does not give 
a good temporal picture because the recording is (a) not 
continuous and (b) patient intervention dependant. 
The current alternative approach for long term rhythm 
monitoring is the implantable loop recorder. During a 
surgical procedure, the device is placed under the skin on 
the chest wall, near the heart. The recorder can monitor 
rhythm for two years or longer. However the recording is 
not continuous. A native warning algorithm monitors 
cardiac electrical activity within a sliding time frame. If the 
algorithm identifies a predetermined dysrhythmia a 
snapshot is taken and stored. The time frame is limited by a 
trade-off between time spent recording and battery life. A 
surgically implanted device is expensive ($2000) and 
comes with the risk associated with a surgical procedure – 
infection, anaesthetic reaction and scar formation. 
Therefore it must function for an extended period to justify 
the risk to the patient, the cost of the device, the surgery, 
post operative hospitalisation and subsequent follow up. 
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II. CLINICAL INVESTIGATION 
 
a. Methodology 
The success of the proposed technology depends on the 
viability of signals recorded on sites such as the wrist, 
forearm and upper arm. These are known as distal 
recording sites. Each site was investigated for signal level 
using the industry standard recovery technique of signal 
averaging (SA). The technique is described fully by 
Escalona et al[8] and is a widely accepted method of small 
potential recovery. 
The study maps the signal degradation as the 
measurement site is moved, away from the heart, along the 
left arm. Ethical approval for the investigation was 
obtained from the Office of Research Ethical Committees 
Northern Ireland (ORECNI). An information leaflet was 
provided to each subject and informed, signed consent 
obtained prior to participation. 
Subjects were selected from the general intake of the 
Craigavon Area Hospital (CAH) cardiology department 
and recordings were carried out on different days, using the 
same room and equipment setup. This was a protocol 
decision made in order to minimise the effects of localised, 
intermittent radiated noise. 
A database of 38 recordings of distal sites along the left 
arm was created. Each recording duration was 500 seconds 
at a sample rate of 2048Hz and 24bit resolution. The bit 
resolution was calculated to be 31.25e-9V. In total 12 
channels plus a reference and a driven right leg (DRL) 
were displaced along the left arm. 
 
b. Clinical data processing  
Each recording was signal average processed using a 
fiducial point obtained from channel 1(CH1) – chest lead 1. 
The strong signal for CH1 allows for the distal channels to 
be temporally aligned and averaged consistently. A 
consistent beat recovery of 98% or greater was achieved 
giving an average beat participation of 348 to 512, 
dependant of the subjects heart rate.  
A comparative noise measurement was achieved using 
a 120mS window centred on a fiducial point and a 40mS 
window displaced along the S-T segment. Temporal 
dispersion was used to generate a signal to noise ratio 
(SNR) for each subject. The results of the six best 
recordings are displayed in table 1. The distance from the 
heart progressively increases from left to right across the 
table, with CH6-2 being on the left wrist. 
 
 
 
 
 
 
Table 1 - Six best case recordings: SNR mean values 
along four distancing bipolar leads along the left arm, to 
the wrist. 
Subject CH1 CH12-11 CH10 CH4 CH6-2 
1 20.97 1.27 1.08 2.23 0.48 
2 13.75 4.93 4.67 10.48 1.81 
3  55.29 36.86 15.67 2.00 1.85 
10 60.59 197.05 22.22 21.23 2.15 
17 37.68 1.49 0.25 0.67 0.16 
36 98.85 3.67 1.01 0.44 4.99 
Mean 47.85 40.88 7.48 6.12 1.91 
 
c. Study conclusion 
The pilot study set out to investigate the signal 
strengths along the left arm and, in particular, the comfort 
zones described by Gemperle et al[9]. The mapped surface 
potentials provide quantitative evidence of the signal levels 
distributed along the arm. A SNR of greater than 1 
demonstrates recovered QRS activity. The study derives 
the broad conclusion that 88% of the 32 recordings deemed 
acceptable from the total 37 group, had a SNR greater than 
1 when using the bicep bipolar channel CH12-11. 
 
III. REALTIME SIGNAL PROCESSING 
The proposed technology will require a real time noise 
reduction algorithm to allow accurate detection of 
anomalies. The latency involved when using signal 
averaging is extensive – 500 seconds.  
 
a. Empirical Mode Decomposition 
Empirical mode decomposition (EMD) is described 
extensively in the literature [10]. Firstly a comparison of 
SA data from Table 1 with an EMD filter was carried out. 
The original data used to generate the SA was truncated to 
a signal length of 10 seconds prior to EMD filtering. A 
further, small study based on an application specific 
protocol was also carried out. A dry electrode technology 
[11] was used to obtain subject data from 2 subjects.  
The data of Table 2 uses the same temporal 
displacement noise comparison technique as that of Table 
1.    
Table 2 - SNR of signal averaged electrocardiogram 
(SAECG) compared to empirical mode decomposition 
(EMD). 
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 Figure 1 shows that a definite improvement in SNR is 
observed when a basic EMD partial recomposition 
technique is used [12]. 
 
Figure 1 – Mean average SNR comparison for six cases 
 
Table 3 presents the data from a small study, n = 2. In 
this instance the aim was to test the feasibility of dry 
electrode use. Each recording utilises a charge amplifier 
recorder and a bipolar electrode pair. The electrodes were 
placed diametrically across the bicep, vectored away from 
the heart. The position was identified, via the primary 
study, to be the best case of the peripheral comfort 
positions identified by Gemperle. Initially subjects were 
recorded in a typical clinical environment, this is referred 
to as a “normal environment”. The second stage of the 
study required that the subjects be rerecorded in a noiseless 
environment. A shielded anechoic chamber was used for 
this activity. Gross patient motion was discouraged for this 
study so as to ascertain a baseline of functionality; 
however, small movements of the left hand were performed 
to create low level electromyographic (EMG) signals.  
Table 3 –Dry electrode comparison between a normal 
environment (N) and an anechoic chamber (C). Mean value 
for n = 2. 
 
 
In each case the data was filtered using the same EMD 
partial reconstruction algorithm used during the 
comparative study. The data shows a considerable, 500% 
increase in the capability of detection when using a 
shielded room. Obviously this technique is impractical, it 
shows, however, that the dry electrode technology is still 
very much in its infancy. Charge amplification utilises an 
extremely high impedence input amplifier which is 
susceptible to both radiated and coupled noise.  
The EMD empirical filtering technique succeeded in 
extracting rhythm information for both subjects. It did so 
with less than 10 seconds of latency. This figure is 
extremely conservative as the majority of the available 
information can be extracted from just one ventricular 
complex, meaning the latency is approximately 1 second. It 
is notable that the EMD filtering process was not 
completely automated during this study. Decomposition of 
the input signal is dependent on its spectral components. 
Different signals will decompose in to varying numbers of 
intrinsic mode functions (IMF’s). On average, the signals 
used during both of the studies mentioned, decomposed 
into 12 IMF’s. However the decomposition was distributed 
between 7 and 15 IMF’s, again dependant on the frequency 
components of the input signal.  More work is required to 
fully utilise the benefits of the EMD process and allow an 
automated filtering algorithm to be produced. 
It was also noted that mode mixing [13] was evident in 
the processed data of several subjects. This phenomena 
leads to a desensitisation of the filtering technique, as the 
IMF’s become no longer monotonic.  This may prove to be 
a fundamental, confounding issue with using EMD in its 
basic state. Further work utilising the Ensemble EMD 
(EEMD) technique [14] may prove to overcome the short 
fall in the suitability of EMD for this application. EEMD 
overcomes the mode mixing issue by mixing white noise 
with the residual component prior to the next phase of 
decomposition. This effectively increases the frequency of 
the splinic envelope, eliminating the aliasing effect which 
caused mode mixing. 
 
IV. HARDWARE CONSIDERATIONS 
A robust recovery method is required to support the 
signal processing. Failure to recover the desired signal is 
irreversible and no amount of post processing will facilitate 
extraction. 
Clinical ECG equipment is described as a single-ended 
recovery system, ie each electrode is referenced to a 
common point electrode, referred to as the CMS electrode. 
Ideally the CMS electrode is placed a reasonable distance 
from the measurement electrode. A single lead ECG 
demonstrates this principle by placing 2 electrodes at 
opposite sides of the chest in order to achieve the 
maximum available signal. A general clinical ECG 
recording, due to the nature of the system, will be subject 
to common mode offset from electrode potential and 
environmental noise. However, the magnitude of the 
recorded signals greatly overrides the system noise, 
meaning that it can be ignored. A distal site ECG recorder 
will not benefit from a greatly displaced common point 
electrode. In order for the proposed device to meet the 
requirements of comfort and practicality, all measurement 
electrodes must be contained within a small area on the 
upper arm or wrist. 
A differential measurement system will provide a 
solution to the majority of the noise sources encountered 
during monitoring. Common mode signals and coupled 
environmental noise will cancel leaving a clean signal 
representative of the bioelectrical activity. Many texts 
describe the use of differential biopotential amplifiers. 
Nagel, J. H. [15] and Webster, J. G. [16] discuss the basic 
requirements of a biopotential amplifier and suggest that 
??
the minimum criteria are: (1) The physiological activity 
should not be disrupted by the measurement process. (2) 
The measured signal must be high fidelity. (3) The 
amplifier must be designed to offer high noise rejection. 
Plessey Semiconductors are in the process of launching 
the EPIC electrostatic-voltometer ASIC in the form of a 
non-contact ECG electrode [11].A prototype of the EPIC 
product was used to record the data presented in Table 3.  
Plessey have also commercialised the EPIC technology as 
a wrist worn heart monitor [17] but have evidently run into 
problems of distal location and signal discrimination 
issues, as the product[18] requires the user to touch a 
conductive pad with a finger from the opposite hand, 
thereby providing maximal electrode displacement and 
offering an increased signal recovery magnitude. 
 
A further alternative to capacitive coupling to allow 
detection of the changes in the body’s electric field, is a 
proximal impedance spectroscopy technique described in 
the industrial patent Lynn et al. US0178902A1 [19]. 
Although the spirit of the patent is biased toward the 
industrial monitoring of carbon fibre composites, the 
technique may lend itself to be effective for the detection 
of small changes in the body’s electric field. Essentially, 
the system uses several transformer windings, displaced 
along a continuous ferrite core, to form a magnetic 
amplifier. The core is swept to determine its resonant 
frequency. The amplitude and frequency of the natural 
resonant frequency (F0) are indicative of the instantaneous 
shunt capacitance (Cp) and shunt resistance (Rp) of the 
proximal body. It is evident that this technique, although 
requiring substantial development, may also be capable of 
detecting an ECG without the requirement for body contact 
or a reference electrode. 
V. CONCLUSION 
The opinion that distal limb recovery of an ECG is 
achievable using technology available today is valid and 
supported by the data presented in this paper. A real-time 
extraction algorithm, utilising an empirical methodology, 
although processor and memory hungry, is achievable 
given the recent advances in portable computing. Today’s 
microprocessors are developed specifically for mobile 
applications and are capable of 10e+8 instructions per 
second or better. Quad core offerings from Intel and ARM, 
to name but a few, have introduced the concept of parallel 
computing into the mobile world. Massive increases in the  
capacity of flash memory means that a device capable of 
running an empirical decomposition algorithm and storing 
months of data on a non-volatile media could be 
manufactured for a modest cost.  
Improvements in silicon manufacturing capability offer 
extremely low power integrated circuits to the market. Low 
power also means low internal noise, allowing for use in 
very low signal amplitude applications such as distal site 
ECG monitoring.   
As with the driving technology (smart phones), battery 
capacity will be the ultimate confounding factor. Long term 
continuous monitoring will require significant battery 
capacity. Until such times as battery technology catches up 
with the demands of portable computing, a redundant cell 
design would allow for hot swapping without an 
interruption in recording. 
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